48 active trials 23 recruiting 11 Phase 3 14 disease areas 2 changes in 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
Recruitment opened
Also in this update: Enrollment increased: 400 → 886 participants
Haisco Pharmaceutical Group Co., Ltd.Phase 3 NCT07581951 Registry history of NCT07581951 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1 | 15 | |
| Phase 1/2 | 2 | |
| Phase 2 | 18 | |
| Phase 3 | 11 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06740201 | A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General… | Anesthesia | Recruiting | 2025-01-27 |
| Phase 3 | ||||
| NCT07581951 | A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH | MASH - Metabolic Dysfunction-Associated Steatohepatitis | Recruiting | 2026-09-23 |
| NCT07583849 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III… | COPD (Chronic Obstructive Pulmonary Disease) | Recruiting | 2026-06-10 |
| NCT07616375 | A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis… | Non-cystic Fibrosis Bronchiectasis | Recruiting | 2026-06-01 |
| NCT07390123 | Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With… | IgA Nephropathy (IgAN) | Recruiting | 2026-05-28 |
| NCT06660992 | A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic… | Non-cystic Fibrosis Bronchiectasis | Recruiting | 2024-10-28 |
| NCT07658339 | A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation… | COPD (Chronic Obstructive Pulmonary Disease) | Not Yet Recruiting | 2026-06-22 |
| NCT07634367 | Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD | COPD (Chronic Obstructive Pulmonary Disease) | Not Yet Recruiting | 2026-06-08 |
| NCT07519070 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate… | IPF | Not Yet Recruiting | 2026-04-09 |
| NCT07510945 | HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric… | General Anesthetic | Not Yet Recruiting | 2026-04-06 |
| NCT07503587 | Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary… | Progressive Pulmonary Fibrosis | Not Yet Recruiting | 2026-03-31 |
| NCT06422117 | Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central… | Central Neuropathic Pain | Not Yet Recruiting | 2024-05-20 |
| Phase 2 | ||||
| NCT07140328 | Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004… | Chronic Obstructive Lung Disease (COLD) | Recruiting | 2026-06-09 |
| NCT07616700 | A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA… | IgA Nephropathy (IgAN) | Recruiting | 2026-06-01 |
| NCT07533786 | A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for… | Pain After Surgery | Recruiting | 2026-05-28 |
| NCT07335055 | A Study for HSK47388 in Participants With Ulcerative Colitis | Ulcerative Colitis (UC) | Recruiting | 2026-03-05 |
| NCT07363460 | Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN | Lupus Nephritis (LN) | Recruiting | 2026-01-23 |
| NCT06745622 | Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal… | Paroxysmal Nocturnal Hemoglobinuria | Recruiting | 2024-12-20 |
| NCT07728721 | Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary… | Idiopathic Pulmonary Fibrosis (IPF) | Not Yet Recruiting | 2026-07-27 |
| NCT07551739 | A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for… | Pain After Surgery | Not Yet Recruiting | 2026-04-27 |
| NCT07108699 | Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler in Chinese Patients… | Chronic Obstructive Pulmonary Disease (COPD) | Active, Not Recruiting | 2026-04-08 |
| NCT07425210 | Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD | Chronic Obstructive Lung Disease (COLD) | Not Yet Recruiting | 2026-02-25 |
| NCT07331402 | A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004… | COPD Patients | Active, Not Recruiting | 2026-01-09 |
| NCT07158268 | A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With… | Plaque Psoriasis | Not Yet Recruiting | 2025-09-05 |
| NCT07150988 | A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe… | Psoriasis | Not Yet Recruiting | 2025-09-02 |
COPD (8) · Idiopathic Pulmonary Fibrosis (3) · Psoriasis (3) · Asthma (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Colorectal Cancer (1) · Diabetes (1) · Lung Cancer (1) · Lupus (SLE) (1) · NASH / MASH (1)